Pemphigus - Diseases of antidesmosomal autoimmunity

JAMA

Volumn 282, Issue 6, 1999, Pages 572-576

  Udey, Mark C ^a   Stanley, John R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PREDNISONE; TETRACYCLINE;

AGED; AUTOIMMUNITY; CASE REPORT; HUMAN; IMMUNOFLUORESCENCE; MALE; NOTE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0033546669     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.6.572     Document Type: Note

References (33)

1. Marinkovich MP, Herron GS, Kavari PA, Bauer EA. Hereditary epidermolysis bullosa. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:690-702.
2. Stanley JR. Pemphigus. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:654-666.
3. Anhalt G, Kim S, Stanley J, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323: 1729-1735.
4. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol. 1997;12:77-96.
5. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley J. Autoantibodies against the amino-terminal cadherin-like domain of pemphigus vulgaris are pathogenic. J Clin Invest. 1992;90:919-926.
6. Lin MS, Mascaro JM, Liu Z, Espana A, Diaz LA. The desmosome and hemidesmosome in cutaneous autoimmunity. Clin Exp Immunol. 1997;107(suppl 1):9S-15S.
7. Sams WMJ, Jordan RE. Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol. 1971;84:7-13.
8. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant proteins. J Immunol. 1997;159:2010-2017.
9. Chowdhury MMU, Natarajan S. Neonatal pemphigus associated with mild oral pemphigus vulgaris in the mother during pregnancy. Br J Dermatol. 1998; 139:500-503.
10. Schlitz JR, Micheal B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol. 1976;67:254-260.
11. Hashimoto K, Shafran KM, Webber PS, Lazaraus GS, Singer KH. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med. 1983;157:259-272.
12. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982;306:1189-1196.
13. Roscoe JT, Diaz L, Sampaio SA, et al. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol. 1985;85:538-541.
14. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol. 1996;11: 319-352.
15. Kowalcyk AP, Bornslaeger EA, Norvell SM, Palka HL, Green KJ. Desmosomes: intracellular adhesive junctions specialized for attachment of intermediate filaments. Int Rev Cytol. 1999;185:237-302.
16. Ding X, Aoki V, Mascara JM, Lopez-Swiderski A, Diaz LA, Fairley JA. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct antibody profiles. J Invest Dermatol. 1997;109:592-596.
17. Amagai M, Nishikawa T, Nousari H. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 1998;102:775-782.
18. Mahoney MC, Aho S, Uitto JR, Stanley JR. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol. 1998;111:308-313.
19. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigen-specific immunoabsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol. 1995;104:895-901.
20. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Absorption of pathogenic antibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest. 1994;94:59-67.
21. Koch PJ, Mahoney MC, Ishikawa H, et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol. 1997;137:1091-1102.
22. Mahoney MG, Wang Z, Rothenberger K, et al. Explanations for the clinical and microscopic localization of lesions of pemphigus foliaceus and pemphigus vulgaris. J Clin Invest. 1999;103:461-468.
23. Wucherpfennig KW, Yu B, Bhol K, et al. Structural basis for major histocompatibilty complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA. 1995;92:11935-11939.
24. Lin MS, Swartz SJ, Lopez A, et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest. 1997;99:31-40.
25. Cohen PL. Systemic autoimmunity. In: Paul WE, ed. Fundamental Immunology. Philadelphia, Pa: Lippincott-Raven; 1999:1067-1088.
26. Shevach EM. Organ-specific autoimmunity. In: Paul WE, ed. Fundamental Immunology. Philadelphia, Pa: Lippincott-Raven; 1999:1089-1125.
27. Sampaio SA, Rivitti EA, Aoki V, Daiz LA. Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, orfogo selvagem (wildfire). Dermatol Clin. 1994; 12:765-776.
28. Moraes ME, Fernandez-Vina M, Lazaro A, et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens. 1997;49:35-40.
29. Eaton DP, Diaz LA, Hans-Filho C, et al, for The Cooperative Group on Fogo Selvagem Research. Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the state of Mato Grosso do Sol, Brazil. J Med Entomol. 1998; 35:120-131.
30. Huilgol SC, Black MM. Management of the immunobullous disorders, II: pemphigus. Clin Exp Dermatol. 1995;20:283-293.
31. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. Arch Dermatol. 1996;132:203-212.
32. Stanley JR. Therapy of pemphigus vulgaris. Arch Dermatol. 1999;135:76-78.
33. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol. 1999; 135:54-56.